Inflammation News and Research

RSS

Early surgical treatment contributes to better outcomes in gallstone pancreatitis cases

Although delaying surgical treatment remains the standard of care for patients with severe gallstone pancreatitis, a new study published in the December issue of the Journal of the American College of Surgeons shows that, contrary to widespread belief, early cholecystectomy -- or surgical removal of the gallbladder -- significantly reduces hospital stays in patients with mild to moderate gallstone pancreatitis with no increase in complications or mortality.

20 Dec 2007

Discovery of molecular signal that helps muscle regenerate and protects it from atrophy

It does not take much to injure a muscle. Sometimes one sudden, inconsiderate movement does the job.

20 Dec 2007

Anthrax vaccine will add to America's arsenal against bioterrorism

A company, based in Rockville, Maryland in the USA, with the help of government funding, has used the human genome to develop a vaccine that may give protection from anthrax.

19 Dec 2007

Severe psoriasis can cut short life

According to a new study having some forms of psoriasis can shorten a person's lifespan.

19 Dec 2007

Addition of antibiotics to MS therapy could slow down progression of the disease

Researchers from Louisiana State University in the U.S. are suggesting that the addition of antibiotics to standard drug therapy for multiple sclerosis, may slow down the progress of the disease.

19 Dec 2007

New understanding on alcohol's role in developing alcoholic chronic pancreatitis

Chronic, excessive alcohol consumption is a major risk factor for developing chronic pancreatitis (pancreatic inflammation).

18 Dec 2007

Intracellular bacterial communities in cystitis; rifapentine cures TB in mouse model; and more

A study published this week in the open access journal PLoS Medicine presents convincing evidence that intracellular bacterial communities (IBCs) commonly exist in women with bladder infections and may contribute to the recurrence of these infections.

18 Dec 2007

Corgenix Medical enters development agreement wth NIH

Corgenix Medical Corporation has announced it has entered into a corporative research and development agreement (CRADA) with the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).

18 Dec 2007

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report funded by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services.

18 Dec 2007

Commonly available antibiotic targets difficult asthma

Hunter researchers have shown that a commonly available antibiotic can improve the quality of life of patients with difficult asthma, and may also generate significant health care savings.

18 Dec 2007

Controlling lupus - new drug targets found

Investigators at Hospital for Special Surgery have identified two new targets for drugs aimed at controlling lupus.

17 Dec 2007

Genetic cause of Kawasaki disease

Researchers from Japan's RIKEN SNP Research Center, collaborating with a team at the University of California, San Diego (UCSD), have discovered a new genetic variation that affects a child's risk of getting Kawasaki disease (KD), an illness characterized by acute inflammation of the arteries throughout the body.

17 Dec 2007

Exposure to traffic pollution can lead to chronic effects in the respiratory health of children with asthma

Exposure to traffic pollution may increase respiratory problems and reduce lung volumes in children with asthma, according to researchers who studied the effects of road and traffic density on children's lung function and respiratory symptoms in the border town of Ciudad Juarez in Mexico.

17 Dec 2007

Preemies' lung function shows prolonged impairment

Many premature babies face serious health challenges, not the least of which is breathing.

17 Dec 2007

Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease

A new study by researchers at Hasbro Children's Hospital, the pediatric division of Rhode Island Hospital, and Mount Sinai Hospital, New York, offers new insight into the role that the cystic fibrosis gene plays in the development of gastrointestinal disease.

14 Dec 2007

Profound immune system discovery opens door to halting destruction of lupus

A researcher funded by the Lupus Research Institute (LRI) has discovered an entirely new and powerful molecular switch that controls the inflammatory response of the immune system.

14 Dec 2007

Molecular 'trip switch' shuts down inflammatory response

Like a circuit breaker that prevents electrical wiring from overheating and bringing down the house, a tiny family of three molecules stops the immune system from mounting an out-of-control, destructive inflammatory response against invading pathogens, researchers at the Salk Institute for Biological Studies have found.

14 Dec 2007

Zebrafish study shows key enzyme in gut is a peacemaker

University of Oregon scientists, using zebrafish to study the gastrointestinal tract, say that an enzyme long assumed to be involved in digestion instead is a detoxifying traffic cop, maintaining a friendly rapport between resident gut bacteria and cells.

13 Dec 2007

Discovery of key mechanism underlying idiopathic pulmonary fibrosis

A study led by Massachusetts General Hospital (MGH) researchers may have found a key mechanism underlying idiopathic pulmonary fibrosis (IPF), a usually fatal lung disease for which transplantation is the only successful treatment.

13 Dec 2007

Cell-tracking software speeds drug development

Time is money, especially in the race to discover new anti-inflammatory drugs and bring them to market.

13 Dec 2007

Inflammation News and Research

Early surgical treatment contributes to better outcomes in gallstone pancreatitis cases

Discovery of molecular signal that helps muscle regenerate and protects it from atrophy

Anthrax vaccine will add to America's arsenal against bioterrorism

Severe psoriasis can cut short life

Addition of antibiotics to MS therapy could slow down progression of the disease

New understanding on alcohol's role in developing alcoholic chronic pancreatitis

Intracellular bacterial communities in cystitis; rifapentine cures TB in mouse model; and more

Corgenix Medical enters development agreement wth NIH

Combining medications often best strategy to battle rheumatoid arthritis

Commonly available antibiotic targets difficult asthma

Controlling lupus - new drug targets found

Genetic cause of Kawasaki disease

Exposure to traffic pollution can lead to chronic effects in the respiratory health of children with asthma

Preemies' lung function shows prolonged impairment

Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease

Profound immune system discovery opens door to halting destruction of lupus

Molecular 'trip switch' shuts down inflammatory response

Zebrafish study shows key enzyme in gut is a peacemaker

Discovery of key mechanism underlying idiopathic pulmonary fibrosis

Cell-tracking software speeds drug development

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News